Jan Geissler
Riemerling, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Correction: Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97).
Journal: Frontiers in oncology
Published: March 23, 2026
Shaping the future of clinical trials through strategic foresight.
Journal: Clinical trials (London, England)
Published: February 26, 2026
Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers.
Journal: The Lancet. Haematology
Published: February 18, 2026
Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97).
Journal: Frontiers in oncology
Published: February 02, 2026
Correction: Methodological study protocol for the European Atlas of clinical trials in cancer and haematology.
Journal: Frontiers in pharmacology
Published: November 10, 2025
Barriers and solutions for healthcare professionals to involve patients as partners in oncology research: Project RISE.
Journal: Future oncology (London, England)
Published: June 11, 2025
Seven Actions Towards Advancing Patient Authorship and Collaboration in Peer-Reviewed Publications.
Journal: The patient
Published: June 05, 2025
Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series.
Journal: The Lancet. Haematology
Published: January 10, 2025
Methodological study protocol for The European Atlas of clinical trials in cancer and haematology.
Journal: Frontiers in pharmacology
Published: January 10, 2025
Last Updated: 09/26/2026